Report Highlights National Cardiovascular Trends in 2014

Share this content:
Report Highlights National Cardiovascular Trends in 2014
Report Highlights National Cardiovascular Trends in 2014

FRIDAY, Jan. 20, 2017 (HealthDay News) -- Cardiovascular trends have been reported using data from four American College of Cardiology National Cardiovascular Data Registries (NCDR). The report was published recently in the Journal of the American College of Cardiology.

Frederick A. Masoudi, M.D., M.S.P.H., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues summarized key findings from four established hospital programs: the CathPCI Registry (data on coronary angiography and percutaneous coronary interventions); the ACTION Registry-GWTG (acute myocardial infarction); the ICD Registry (implantable cardioverter defibrillators and cardiac resynchronization therapy); and the IMPACT Registry (catheterization procedures for congenital heart disease in children and adults).

The authors note that there were 667,424 patients undergoing PCI in 2014. The median door-to-balloon times for primary PCI for ST-segment elevation myocardial infarction were 59 and 105 minutes for patients receiving PCI at the presenting hospital and for transfer patients, respectively. In the ICD registry, 158,649 patients received ICD therapy in 2014. Performance on a composite medication metric could be a target for quality improvement efforts, although there was an increase in the composite rate of use from 76.7 to 80.3 percent between 2011 and 2014. In the ACTION-GWTG Registry, room for improvement was identified in areas such as overall defect-free care and P2Y12 inhibitor use. The IMPACT Registry included data for 20,169 patients with congenital heart disease undergoing cardiac catheterization or a catheter-based intervention. Many procedures were performed with success rates exceeding 84 percent; aortic coarctation balloon angioplasty was less often successful (55.1 percent).

"NCDR data provide a unique, clinically rich national perspective on the care and outcomes of high-impact cardiovascular conditions and procedures that are not available elsewhere," the authors write.

Executive Summary
2016 Report

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Greater resolution of nodules with hyaluronidase versus saline; more rapid resolution with higher doses

Improvement in Race-Based Disparities in Years of Life Lost

Improvement in Race-Based Disparities in Years of Life ...

Decline in race-based disparities in years of life lost seen in the United States from 1990 to 2014

Drug-Related Endocarditis Cases Up From 2007 to 2015

Drug-Related Endocarditis Cases Up From 2007 to 2015

Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use

is free, fast, and customized just for you!

Already a member?

Sign In Now »